Sildalis

Market Realities And Patient Experiences

• INN (International Nonproprietary Name): Sildalis does not have an official INN and is a combination medication containing two active ingredients: sildenafil citrate (INN: sildenafil) and tadalafil (INN: tadalafil.
• Brand Names Available In United Kingdom: Sildalis is marketed as a non-innovator, mostly internet-sold combination drug that merges the active ingredients of Viagra (sildenafil) and Cialis (tadalafil). Packaging typically shows red, oval tablets in blister packs and labelling is often in English or Russian. It is primarily available through online pharmacies and unofficial distributors rather than registered local pharmacies.
• ATC Code: G04BE03 (for sildenafil) and G04BE08 (for tadalafil).
• Forms & Dosages: Sildalis is sold as tablets, commonly with each tablet containing 100 mg sildenafil + 20 mg tadalafil, in blister packs of 6–20 tablets.
• Manufacturers In United Kingdom: Not specified.
• Registration Status In United Kingdom: Not registered with MHRA as a fixed-dose combination product; no public record of a combined sildenafil/tadalafil preparation approved or listed by major regulators.
• OTC / Rx Classification: Prescription only (Rx) in jurisdictions where sildenafil or tadalafil are regulated. Sildalis is nevertheless sold without prescription by some online shops operating outside regulated supply chains.

Online Demand, Anecdotal Reports And Why Shoppers Choose Sildalis

Are people searching for something faster-acting and longer-lasting than a single PDE5 inhibitor?

Yes — many internet searches and forum posts show men looking for an “enhanced potency” ED pill that promises both rapid onset and extended duration.

Buyers are often motivated by convenience, perceived value and marketing that calls Sildalis a dual-action ED pill.

Some people choose online purchase to avoid GP consultations or to keep the issue private.

Forum reports and seller reviews commonly say the combination gives a faster start than tadalafil alone and a longer effect than sildenafil alone.

Patient reports are inconsistent and lack clinical verification, so they cannot replace formal studies.

Practical product-page content must set realistic expectations on timing, variability in effect, sourcing risks and encourage consultation with a clinician.

• Common Patient-Reported Benefits: Faster perceived onset, longer usable window, convenience of a single tablet.
• Common Patient-Reported Complaints: Stronger side effects, variable response between batches, uncertainty about provenance and labelling.

Sourcing Risks

• Counterfeit Products: Some internet-sold batches lack genuine manufacturer data or batch numbers.
• No MHRA Registration: The combination is not approved as a fixed product in MHRA registries.
• Quality Uncertainty: Manufacturing is mainly by third-party suppliers outside official Western supply chains.

How UK Patients Typically Buy Sildalis (Online Vs NHS Route)

Pathways, Prescriptions And Pharmacist Consultations

Which routes do UK patients normally take for ED treatment?

Treatment for erectile dysfunction in the UK usually runs through the NHS or private clinics where licensed drugs are dispensed by Boots, Superdrug or LloydsPharmacy and via electronic prescriptions.

Sildalis, however, is most frequently encountered through online vendors and direct-to-web suppliers operating outside regulated supply chains.

The product is not registered with major regulators and is often sold without prescription by some online shops, so buying it bypasses NHS clinical screening.

Sildenafil and tadalafil individually are prescription only in the UK, so the legal and ethical boundary should be explained clearly on any product page.

Pharmacist consultations and electronic prescriptions provide safety screening that online unregulated sellers do not.

Electronic Prescription

An NHS or private prescriber issues a prescription digitally to a registered pharmacy.

MHRA-Registered

A product or manufacturer listed on the UK Medicines and Healthcare products Regulatory Agency register.

Unlicensed Import

Medicines brought into the UK that are not authorised as advertised by the MHRA.

Clinical Advice

Always advise patients to talk to a GP or pharmacist before buying an ED medicine and to seek pharmacist-led screening where possible.

Packaging, Manufacturers And Global Availability

Typical Packaging, Known Manufacturers And Market Sources

What does a Sildalis pack typically look like?

Typical packaging shows red, oval tablets in blister packs, often labelled in English or Russian.

Manufacturing is mainly by smaller Indian generic companies or direct-to-web suppliers such as RSM Enterprises or Sunrise Remedies rather than by originator firms.

Distribution is concentrated through internet channels and not through official registered supply chains in Western markets.

A product page should include provenance details where available and any lab verification that the seller can provide.

Checklist For Spotting Counterfeit Packaging

• Check for a clear batch number and expiry date printed on the blister or box.
• Look for spelling mistakes or poor print quality on the label.
• Compare tablet shape and colour to trusted references; red oval tablets are typical.
• Be wary of unreasonably low prices or sellers that refuse to provide manufacturer details.

Note that lack of UK supply-chain registrations increases the risk of poor manufacturing or counterfeit products.

Legal And Regulatory Status In The UK And Internationally

MHRA, NHS Stance And Consumer Protection

Is Sildalis approved by the MHRA or other major regulators?

No fixed-dose combination of sildenafil and tadalafil is registered with agencies such as the MHRA, EMA or FDA.

Sildalis is not an official INN and there is no public record of regulatory approval for this combination product.

Sildenafil and tadalafil individually are regulated and prescription only in the UK, and those products are covered by MHRA oversight.

Purchasing combined products from unregulated sellers may forfeit legal protections and complicate the ability to report adverse events.

Unlicensed Import

Importing medicines that do not have local authorisation; these may lack UK regulatory oversight.

Off-Label

Using a licensed medicine in a manner not described in its authorised product information.

Prescription-Only

Medicines that legally require a prescriber before supply in the UK.

Patients should seek GP guidance and use licensed pharmacy channels where possible.

Composition, Dose Strengths And What Each Tablet Contains

Active Ingredients, Typical Strength And Labelling Practices

What is inside a Sildalis tablet?

Each marketed Sildalis tablet commonly contains 100 mg sildenafil plus 20 mg tadalafil.

Both act as phosphodiesterase type 5 (PDE5) inhibitors and are the INNs sildenafil and tadalafil respectively.

Typical packaging is blister-packed tablets in counts of 6–20.

INN

International Nonproprietary Name; Sildalis does not have an INN for the combination.

ATC Codes

G04BE03 (sildenafil) and G04BE08 (tadalafil).

Combination Product

A medicine that contains two active pharmaceutical ingredients in one dosage form.

Excipients and allergen information should be listed where available and must be checked before supply.

Pharmacology And Expected Onset/Duration Of Effect

How Sildenafil And Tadalafil Combine And What To Expect

How do the two act together?

Both sildenafil and tadalafil inhibit PDE5 and increase penile blood flow in response to sexual stimulation.

Sildenafil generally has onset in 30–60 minutes and several hours of effect, while tadalafil has a slower onset and can last up to 36 hours.

Combining the two aims to deliver the faster onset of sildenafil with the prolonged duration of tadalafil, but the pharmacokinetics of the fixed-dose combination are not officially characterised by regulators.

Buyers should be reminded that safety and PK for the combination are not formally established and that responses vary between individuals.

Factors That Influence Individual Response

• Food intake, particularly a heavy fatty meal, which can delay sildenafil absorption.
• Alcohol, which can reduce efficacy and increase side-effect risks such as dizziness.
• Cardiovascular status and concurrent medications, which can alter drug effects.

It is sensible to trial a single dose under clinician oversight and to avoid combining with other unapproved agents.

Contraindications And Key Drug Interactions

Absolute And Relative Contraindications To Highlight On The Product Page

Who must not take Sildalis?

Absolute contraindications include known allergy to sildenafil or tadalafil, concurrent use of nitrates and use with riociguat for pulmonary hypertension.

Severe cardiovascular disease that makes sexual activity unsafe is another absolute contraindication.

Relative cautions include recent myocardial infarction or stroke, unstable angina, severe hepatic or renal impairment and rare retinal disorders such as retinitis pigmentosa.

Absolute Contraindications

• Concurrent use of nitrates — risk of life-threatening hypotension.
• Concurrent use of riociguat — contraindicated.
• Known allergy to sildenafil, tadalafil or excipients.

Relative Contraindications / Cautions

• Recent MI or stroke, unstable angina or severe heart failure.
• Significant hepatic or renal impairment — dose adjustment for individual ingredients is usually required.
• Retinitis pigmentosa or other hereditary retinal disorders.

Important Safety Prompt

Do not take Sildalis if you are on nitrates — seek urgent medical advice if you have already combined them.

Side-Effect Profile, Monitoring And Red-Flag Symptoms

Common Adverse Effects And When To Seek Help

What side effects should patients expect?

Common side effects mirror those of sildenafil and tadalafil and include headache, flushing, nasal congestion, dizziness and indigestion.

Tadalafil is more associated with back and muscle pain, while sildenafil can cause transient visual disturbances.

Because the tablet exposes the body to both drugs, additive adverse effects such as hypotension, severe headache, visual symptoms or priapism may be more likely.

Common Effects

• Headache.
• Flushing and nasal congestion.
• Dizziness and indigestion.
• Visual changes such as blurred vision or a bluish tinge.
• Back or muscle pain.

Serious Red Flags — Seek Urgent Care

• Priapism — painful erection lasting more than four hours.
• Sudden vision loss or sudden decrease in vision.
• Sudden hearing loss or ringing in the ears with dizziness.
• Chest pain, severe dizziness or fainting.

Patients should be advised to stop the medicine and seek immediate care for any red-flag symptoms and to report adverse events to the MHRA Yellow Card scheme if purchased in the UK.

Comparing Sildalis With Viagra And Cialis (Practical Differences)

Efficacy Claims, Onset, Duration And Safety Trade-Offs

How does Sildalis compare to branded options?

Viagra (sildenafil) and Cialis (tadalafil) are single-agent, well-documented products with MHRA and EMA registrations in many markets.

Sildalis is an unregulated combination largely marketed online and lacks controlled evidence for combined dosing, pharmacokinetics and long-term safety.

Practical claims for Sildalis combine sildenafil’s faster onset with tadalafil’s prolonged duration, but clinical validation is absent.

Licensed alternatives allow pharmacist-led screening, legal dispensing and clearer post-marketing surveillance.

Practical Dosing Advice, Administration And Missed-Dose Guidance

How To Use Sildalis Safely And Realistic Expectations

How should the marketed tablet be used?

Standard marketed tablet strength is 100 mg sildenafil + 20 mg tadalafil, taken once about 30–60 minutes before sexual activity and not more than one tablet per 24 hours.

Because Sildalis is taken as needed, there is no missed-dose protocol.

Advise taking on a lighter stomach to reduce delay from a heavy meal and warn that alcohol reduces efficacy and increases adverse-effect risk.

• Take one tablet approximately 30–60 minutes before sexual activity.
• Do not take more than one tablet in any 24-hour period.
• Avoid heavy meals before dosing and limit alcohol intake.

FAQs

Can I take Sildalis daily? No — marketed use is as-needed; daily use is not supported for the fixed combination.

What if I miss a dose? Not applicable for as-needed dosing.

Start with clinician review and consider a lower starting dose if frail or elderly.

Special Populations: Elderly, Hepatic/Renal Impairment, And Women/Children

Who Should Avoid Or Modify Dosing And What Evidence Is Missing

Is Sildalis studied in older adults or children?

Sildalis is not approved for children or women for erectile dysfunction and safety and efficacy are unstudied in these groups.

Elderly patients and those with significant liver or kidney impairment require cautious dosing for the individual ingredients but there are no formal dose-adjustment studies for the combination.

Product pages should advise clinician assessment before use in older adults, monitor for hypotension and interactions, and avoid use where clearance of PDE5 inhibitors is substantially reduced.

Elderly

Start at the lowest effective dose and monitor for hypotension and other side effects.

Hepatic/Renal Impairment

Both sildenafil and tadalafil may require lower doses; Sildalis has no specific guidance.

Women/Children

Not approved; avoid use for ED in these groups.

Pharmacy staff should follow a clear decision tree and seek GP sign-off when in doubt.

Overdose, Emergency Responses And Handling Adverse Events

Symptoms, First Aid And Reporting Procedures

What to do in an overdose or severe reaction?

Overdose may cause severe hypotension, syncope, prolonged erection (priapism) and intensified visual or neurological disturbances.

For overdose or severe reactions, emergency services should be contacted and management in hospital is symptomatic and supportive.

Patients should be instructed to seek immediate care for priapism lasting more than four hours, chest pain or sudden visual or hearing loss.

• Emergency-action checklist: stop the medicine, call NHS 111 or emergency services for severe symptoms.
• Priapism lasting >4 hours requires urgent hospital attendance to avoid permanent damage.
• Record and report adverse events to the MHRA Yellow Card scheme in the UK.

Storage, Transport, Packaging Integrity And Counterfeit Risks

How To Store Sildalis And Spot Suspicious Products

How should Sildalis be stored?

Store below 30°C, away from moisture and direct sunlight, and keep out of reach of children.

Because Sildalis is commonly sold online, product integrity and counterfeit risk are heightened.

Customers should check batch numbers, expiry dates and packaging seals on arrival and compare labelling to manufacturer details where possible.

Incoming Parcel Checklist

• Check for intact seals and a clear batch number and expiry date.
• Inspect for misspelt labels, poor printing or lack of manufacturer details.
• Be suspicious of unusually low prices or sellers who refuse returns.

Buying Guidance, Pricing, Reimbursement And Pharmacy Policy (UK-Focused)

Private Vs NHS Cost, Where To Buy Legally And Pharmacy Responsibilities

How much does treatment usually cost and where can it be bought legally?

Sildenafil and tadalafil are prescription-only in the UK and are available from NHS or private prescribers with dispensing via registered pharmacies such as Boots, LloydsPharmacy or Superdrug.

Sildalis is typically unavailable through regulated pharmacy channels and buying it online from unregulated sellers removes pharmacist screening and legal protections.

In our online pharmacy, sildalis is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Pharmacy Policy Notes

• Pharmacies should refuse supply if a patient presents unverified or suspect product and offer licensed alternatives instead.
• Document counselling and provide clinical screening for cardiovascular history and interacting medicines.
• Use electronic prescriptions and registered dispensing channels where possible.

Patient Counselling Checklist And Follow-Up Plan For Pharmacy Product Page

What Pharmacists Must Communicate And Recommended Follow-Up

What should pharmacists tell a patient considering Sildalis?

Confirm the indication is erectile dysfunction and review cardiac history, nitrate use and current medicines, especially CYP3A4 inhibitors.

Discuss likely side effects and red flags such as priapism, sudden vision or hearing loss, and chest pain.

Advise on timing, food and alcohol interactions and recommend GP review after first use.

• Check cardiac history and nitrate use before supply.
• Review other medicines and potential CYP3A4 interactions.
• Explain dosing: one tablet 30–60 minutes before activity and no more than one per 24 hours.
• Highlight common side effects and the emergency red-flag symptoms.
• Arrange follow-up: a phone check within 1–2 weeks and GP review for recurrent use.

Document counselling thoroughly and report any adverse events to the MHRA Yellow Card system.

Delivery Across United Kingdom